Aptalis Pharmaceutical Technologies: White Papers

Minimizing Time to Market: Developing Consumer Health Products Under the US OTC Drug Monograph
Thursday, January 26, 2012 by Aptalis Pharmaceutical Technologies With the tightening of R&D budgets and increased pressure from financial stakeholders, the pharmaceutical industry faces a great challenge in bringing profitable drug products to market...

Novel Formulations to Improve the Control of Emesis
Tuesday, January 24, 2012 by Aptalis Pharmaceutical Technologies Reformulation is a key strategy for product development and helps address the challenges of the current market, such as longer new chemical entity (NCE) development timelines, fewer new...